S H L Telemedicine Ltd (SHLTN) Fair Value & Analysis

Healthcare · CH · Market cap CHF 38.9M · ISIN IL0010855885

Below-average quality, trading 20% below our fair value.

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

• Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
• Our model range runs from CHF 1.07 (bear) to CHF 1.60 (bull), base CHF 1.33. The closer the price sits to the lower half, the larger the margin of safety.
• Quality 37/100 (below-average quality) with low evidence: read the verdict with care.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 18, 2026.

How to read this chart

60‑month range CHF 0.4565 – CHF 11.00 · fair‑value band CHF 1.07 – CHF 1.60 · the CHF 1.07 price screens below the CHF 1.33 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Aug 18, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

S H L Telemedicine Ltd (SHLTN) currently trades at CHF 1.07, while our model-based Fair Value estimate is CHF 1.33, implying the stock looks roughly 24.7% undervalued today. The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Over the trailing twelve months, S H L Telemedicine Ltd generated revenue of CHF 58.7M at a net margin of -26.2%. Revenue grew 6.5% year over year. It earns a return on equity of -37.1%. The balance sheet holds a net cash position of CHF 12.2M. Fundamentals as of Aug 18, 2026

Our scenario range runs from CHF 1.07 (bear case) to CHF 1.60 (bull case); at CHF 1.07, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 28% below its 52-week high and 178% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -68% fair-value upside, at 25%, SHLTN screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: Multiples (CHF 1.74) versus Asset-Based (CHF 0.7900). Highest evidence: EV/EBITDA (67).

Key figures & financial health

Quality Score breakdown

About the company

SHL Telemedicine Ltd., together with its subsidiaries, provides telemedicine services in Israel, Europe, and internationally. The company offers SmartHeart platform, a 12-lead electrocardiogram (ECG) that enables a full, hospital-quality ECG to be performed by a lay-person without the assistance of a healthcare professional.

Full company description

SHL Telemedicine Ltd., together with its subsidiaries, provides telemedicine services in Israel, Europe, and internationally. The company offers SmartHeart platform, a 12-lead electrocardiogram (ECG) that enables a full, hospital-quality ECG to be performed by a lay-person without the assistance of a healthcare professional. It also provides preventative healthcare, including annual medical check-ups that include comprehensive laboratory tests, stress ECG tests, eye exams, and others; witness services for medical experts and medical committees; and occupational healthcare, including occupational safety and health regulated medical exams, exposure to hazardous materials, and occupational disability claims, as well as assisting organizations in promoting early detection of diseases and medical conditions within the workforce by offering periodical check-ups and specialized examinations. In addition, the company offers medical examinations, including at home, for the underwriting of insurance policies for health, disability, life, or nursing home policyholders; medical and psychological evaluations, including for truck drivers, public transportation drivers, and drivers of hazardous cargos; remote monitoring of chronic patients; telehealth hot-line services; and doctors' virtual visits. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart 12 lead ECG. SHL Telemedicine Ltd. was incorporated in 1986 and is headquartered in Tel Aviv-Yafo, Israel.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

S H L Telemedicine Ltd reported revenue of $61.5M in FY2025 versus $49.6M in FY2021, a compound +5.5%/yr. Reported net income was −$16.1M in FY2025.

Watch SHLTN: get an alert when its fair value changes →

Peer Group

Health Information Services · 131 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Health Information Services median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Aug 18, 2026).

Explore undervalued stocks

More undervalued Healthcare stocks →

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

Discover tools

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.